C

CSPC Pharmaceutical Group Ltd
HKEX:1093

Watchlist Manager
CSPC Pharmaceutical Group Ltd
HKEX:1093
Watchlist
Price: 4.8 HKD -0.21% Market Closed
Market Cap: 56.1B HKD
Have any thoughts about
CSPC Pharmaceutical Group Ltd?
Write Note
CSPC Pharmaceutical Group Ltd
/
Balance Sheet
/
Additional Paid In Capital

CSPC Pharmaceutical Group Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CSPC Pharmaceutical Group Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Additional Paid In Capital
¥489.1m
CAGR 3-Years
119%
CAGR 5-Years
60%
CAGR 10-Years
30%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Additional Paid In Capital
¥14.1B
CAGR 3-Years
0%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Additional Paid In Capital
¥1.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Additional Paid In Capital
¥3.2B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
21%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Additional Paid In Capital
¥17.6B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
30%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Additional Paid In Capital
¥858.7m
CAGR 3-Years
294%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CSPC Pharmaceutical Group Ltd
Glance View

Market Cap
57.1B HKD
Industry
Pharmaceuticals

CSPC Pharmaceutical Group Ltd., a prominent player in the pharmaceutical industry, has charted a strategic path focused on innovation and a diversified portfolio. The company, with its roots in China, has emerged as a formidable force by blending traditional pharmaceutical manufacturing with a strong emphasis on research and development. CSPC's journey is characterized by a commitment to developing high-quality generic drugs, innovative therapeutics, and nutritional products. The company's core business revolves around the production and sale of a wide range of pharmaceuticals, including cardiovascular drugs, oncology treatments, and central nervous system therapies. By leveraging advanced technology and robust research initiatives, CSPC consistently delivers solutions that address both common and complex healthcare needs across the globe. With a strategic focus on both domestic and international markets, CSPC Pharmaceutical Group capitalizes on its extensive distribution network to maximize reach and impact. The company has made significant investments in its production capabilities to maintain stringent quality standards while achieving cost efficiency. Furthermore, CSPC's earnings are bolstered by its expanding pipeline of innovative drugs, developed in-house and through strategic collaborations, which aims to capture emerging therapeutic areas. Overall, CSPC's blend of traditional pharmaceutical expertise, a focus on innovation, and strategic market positioning enables it to maintain a strong operational foothold and to consistently drive revenue growth in an ever-evolving industry landscape.

Intrinsic Value
7.28 HKD
Undervaluation 34%
Intrinsic Value
Price
C
What is Intrinsic Value?

See Also

What is CSPC Pharmaceutical Group Ltd's Additional Paid In Capital?
Additional Paid In Capital
489.1m CNY

Based on the financial report for Sep 30, 2024, CSPC Pharmaceutical Group Ltd's Additional Paid In Capital amounts to 489.1m CNY.

What is CSPC Pharmaceutical Group Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
30%

Over the last year, the Additional Paid In Capital growth was 68%. The average annual Additional Paid In Capital growth rates for CSPC Pharmaceutical Group Ltd have been 119% over the past three years , 60% over the past five years , and 30% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.